Integrating surgical intervention and watch-and-wait approach in dMMR metastatic rectal cancer with pembrolizumab: a case report
Yohei Ando(Japanese Foundation For Cancer Research), Yosuke Fukunaga(Japanese Foundation For Cancer Research), Tsubasa Sakurai(Kyushu University), Toshiki Mukai(Japanese Foundation For Cancer Research), Izuma Nakayama(National Cancer Center Hospital East), Tomohiro Yamaguchi(Japanese Foundation For Cancer Research), Takashi Akiyoshi(The Japanese Society of Gastroenterological Surgery), Akiko Chino(Japanese Foundation For Cancer Research), Kosuke Ozaki(Japanese Foundation For Cancer Research), Yasuyuki Shigematsu(The Cancer Institute Hospital), Atsushi Oba(Japanese Foundation For Cancer Research), Shimpei Matsui(Keio University)
Cited by 4
Related Papers
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system
|Cancer Science|2014|238
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer
|International Journal of Clinical Oncology|2021|157
Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212
|European Journal of Surgical Oncology|2016|138
Learning curve for robotic-assisted surgery for rectal cancer: use of the cumulative sum method
|Surgical Endoscopy|2014|132
Open versus Laparoscopic Surgery for Advanced Low Rectal Cancer
|Annals of Surgery|2017|121